Tirze GLP-1 Double Agonist

Description

Tirze GLP-1 is a once-weekly injectable medication designed to treat Type 2 diabetes and chronic weight management. Marketed as Mounjaro (for diabetes) and Zepbound (for weight loss) by Eli Lilly, it functions as a dual GIP and GLP-1 receptor agonist, reducing appetite, slowing digestion, and improving blood sugar control.

Free Reconstitution Calculator For Research:  http://onlinepeptidecalculator.com/

For more in depth information: https://pubchem.ncbi.nlm.nih.gov/compound/156588324